Jeevan Scientific Technology's Financial Performance Declines
Jeevan Scientific Technology, a microcap pharmaceutical and drug company, has reported a decline in net sales, net profit, and operating profit for the quarter ended September 2023. The company's stock has been given a 'Sell' rating by MarketsMojo due to its poor financial performance. This news is relevant for investors in the pharmaceutical industry.
Jeevan Scientific Technology, a microcap pharmaceutical and drug company, has recently announced its financial results for the quarter ended September 2023. The company's net sales for the quarter have decreased by 22.43% compared to the previous quarter, while the consolidated net profit has shown a decline of 215.38%. The operating profit (PBDIT) excluding other income has also seen a significant decrease of 70.44% in the quarter.The company's interest expenses, however, have increased by 13.04% in the quarter. The operating profit margin (excluding other income) has also fallen compared to the previous quarter.
MarketsMOJO, a leading financial analysis and research firm, has given a 'Sell' call for Jeevan Scientific Technology's stock. The company's quarterly analysis highlights a decline in key financial metrics, leading to a decrease in its overall score from 2 to 0 in the last 3 months.
Jeevan Scientific Technology has not shown any significant growth in the quarter and its financial performance has been flat. The company's stock has been recommended as a 'Sell' by MarketsMOJO. This news is important for investors to make informed decisions about their investments in the pharmaceutical and drug industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
